
Being hospitalized a second time for recurrent cases of C difficile created worse outcomes for patients and increased hospital costs.


C Difficile Risk Factors for Patients with Inflammatory Bowel Disease

Overcoming Resistance to Catheter-Directed Therapy in Submassive Pulmonary Embolism

Being hospitalized a second time for recurrent cases of C difficile created worse outcomes for patients and increased hospital costs.

Research demonstrates that medication-assisted treatment for opioid addiction works, yet few have adopted it.

A retrospective review of rural region's hospitals found that even the discharge time of day could be associated with a greater chance of readmission.

Keith Kaye, MD, MPH discusses the current successes and challenges in addressing multidrug-resistant infections, as well as expectations for how recommendations will change in the future.

Roche's investigative drug could become the first single-dose oral antiviral approved for the US market in December.

In review of US-based infections during the 2016 outbreak, investigators found more telling indicators of the virus are patients' proximity to other infected patients, and their desire to be tested.

Patients who acquired C difficile infection while in the hospital were more than twice as likely to be discharged somewhere other than home, such as to a nursing home or long-term care facility.

Electronic medical records alerts about patients at risk for C difficile infection seemed to increase the incidence, but investigators pointed toward improved detection as the culprit.

Pivotal clinical trial costs increased if more patients were needed to document treatment benefit, if active drug comparators were used, or to measure clinical end points rather than a change in a surrogate outcome.

Placing patients with community-acquired C difficile infection in single-occupancy hospital rooms may not be necessary to prevent the spread of C difficile, suggests a recent study.

A face-to-face, case-specific education intervention improved the management practices among nurses who cared for hospitalized patients with C difficile infections.

A quarter of surveyed second-year residents reported high emotional exhaustion and depersonalization. Nearly half reported weekly symptoms of burnout.

A new study is the first to identify eosinophil counts as a predictor of outcomes in human patients.

A new meta-analysis aimed to quantify the effect, if any, of physician burnout on patient wellbeing. They found the links are strong and consequential.

A whitepaper presents practical, expert opinion-based recommendations for preventing and testing for C difficile infection in the NICU.

Stay up to date on the latest product recalls issued by the FDA this past week.

Investigators found 16S rRNA gene qPCR to be more sensitive than culture for detecting C difficile on environmental surfaces.

More than 2 million US outpatient visits and 3 million emergency department visits from 2005-2009 were accounted to children seeking care for mild TBI. Until now, no evidence-based clinical guidelines for pediatric mild TBI existed.

The results of a recent study revealed that the implementation of a comprehensive care plan for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) can be successful in reducing both readmission and mortality rates.

A new study has found that, based on the complexities of the EHR system they're required to use, physicians have a nearly equal chance of shortening or extending their career.

What a longtime family practitioner in a state that authorizes medical aid in dying has learned through his own experience of the controversial practice.

As more physicians are caring for transgender patients, many are finding they are unprepared and they lack the training, skills, and resources to do so, according to the authors of a recent review article.

A new survey found that Clostridium difficile infections have a substantial impact on the health-related quality of work, work life, and physical activity of those who are infected.

Ridinilazole caused less microbiota disruption, and investigators believe it may be superior to vancomycin for preventing Clostridium difficile infection recurrence.

Research indicates that rates of Clostridium difficile infection among those typically not considered at high risk of infection are increasing, and these infections are becoming more frequent, severe, and difficult to treat.